Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity

ClinicalTrials.gov ID: NCT01203436

Public ClinicalTrials.gov record NCT01203436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial was to determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to threshold ROP and the need for peripheral retinal ablation.

Study identification

NCT ID
NCT01203436
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Enrollment
649 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 48 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 1994 (Type not available)
Primary completion
Mar 1999 (Actual)
Completion
Mar 1999 (Actual)
Last update posted
Jun 8, 2015

1994 – 1999

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
Stanford University Palo Alto California 94304 —
Yale University New Haven Connecticut 06504 —
Emory University Atlanta Georgia 30303 —
Indiana University Indianapolis Indiana 46202 —
Wayne State University Detroit Michigan 48201 —
Cincinnati Children's Medical Center Cincinnati Ohio 45267 —
Brown University, Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 —
University of Tennessee Memphis Tennessee 38163 —
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01203436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2015 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01203436 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →